Post by
xodcode on Sep 09, 2024 11:13am
New Cancer Treatment
Anyone watching SUMMIT (SMMT) today: up 50% plus last time I checked. Results beat Keytruda!
Comment by
DeathXray33 on Sep 09, 2024 11:32am
"Ivonescimab Is the First Drug to Achieve Clinically Meaningful Benefit over Pembrolizumab" ------------------------- Meaningful Benefit ??? Hmm... ;-)---------- @ > 1.532 million now.
Comment by
N0taP00p on Sep 09, 2024 11:39am
Had been watching it but didn't pull the trigger. They have big US VCs backing them. If TLT were in the US, would probably be sitting at 5 bucks easy, with the kind of data they have. Of course, the VCs would push much harder for results too. Maybe we finally get a big jump like SMMT in early October.
Comment by
riverrrow on Sep 09, 2024 1:08pm
It was certainly my dream for TLT to be trading at $5 while I owned over a million tradeable warrants. Sad sigh.
Comment by
DeathXray33 on Sep 11, 2024 3:38pm
I just reread that news release; it makes no sense. Can anyone decipher it? "Meaningful benefit" , "Manageable safety", "Reduce the risk of" ? 16.64 Billion MC ? --------------------- It seems to be written in the Slickconian language. An ancient Demon language used to deceive. Only a few here can decipher the Slickconian language.
Comment by
O12009 on Sep 11, 2024 4:11pm
The trial was done in China with no peer review very few results to go by. That treatment is a long way off as they will need to do a trial with FDA approval and be recognized by the majority of the free world.